Sorafenib Induces Therapeutic Response in a Patient with Metastatic Collecting Duct Carcinoma of Kidney

Publisher： Karger

E-ISSN： 2296-5262|32|1-2|44-46

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.1-2, 2009-01, pp. : 44-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER2 Blockade in Metastatic Collecting Duct Carcinoma (CDC) of the Kidney: A Case Report

By  

Oncology Research and Treatment, Vol. 35, Iss. 12, 2012-11 ,pp. : 776-779

Karger

Access to resources Recommend Favorite

Collecting Duct Carcinoma

By  

Urologia Internationalis, Vol. 67, Iss. 1, 2001-07 ,pp. : 86-90

Karger

Access to resources Recommend Favorite

Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-02 ,pp. : 83-87

Karger

Access to resources Recommend Favorite

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma

By  

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-09 ,pp. : 450-455

Karger

Access to resources Recommend Favorite

Immunohistochemical Study of bcl-2, p53 and Ki-67 Expressions in Collecting Duct Carcinoma of the Kidney

By  

Urologia Internationalis, Vol. 69, Iss. 1, 2002-07 ,pp. : 57-62

Karger

Access to resources Recommend Favorite